|07th March,2023||Track 3|
AI is an essential tool in healthcare and the longevity and healthy ageing sectors are no exception. AI has already contributed to the identification of longevity biomarkers and can further contribute to the development of personalised health and the acceleration of diagnosis. What concrete steps in the use of AI in longevity and ageing research have already been taken? How to use this tool efficiently and in what area of the ageing research? What are its limitations? Are the costs and administrative burden of implementing AI-based solutions worth the medical benefits they bring? What can be foreseen for the future?